insights_auto
Why is LYEL up २.५०%?
Dive Deeperchevron_right
LYEL:NASDAQ
Lyell Immunopharma Inc
US$ ८.१९
arrow_upward
+२.५०%(+०.२०) 1D
US$ ८.१९
०.००% (०.००)
bedtimeAfter hours
Closed: अक्टोबर १५, १६:००:०१ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LYEL...
Open
US$ ८.००
High
US$ ८.४४
Low
US$ ७.७६
Mkt. cap
२०.०७ करोड
Avg. vol.
१.५० लाख
Volume
०.००
52-wk high
US$ ४५.००
52-wk low
US$ ७.३२
EPS
-US$ १२.०१
Beta
-०.०३
Shares outstanding
२.४५ करोड
No. of employees
१६१
Open
US$ ८.००
High
US$ ८.४४
Low
US$ ७.७६
Mkt. cap
२०.०७ करोड
Avg. vol.
१.५० लाख
Volume
०.००
52-wk high
US$ ४५.००
52-wk low
US$ ७.३२
EPS
-US$ १२.०१
Beta
-०.०३
Shares outstanding
२.४५ करोड
No. of employees
१६१
News stories
From web sources and news partners
Profile
Lyell Immunopharma, Inc. is an American clinical-stage biopharmaceutical company headquartered in San Francisco, California. Founded in 2018, the company develops next-generation cell therapies, including CAR T cell, using technologies intended to improve T-cell persistence, function, and resistance to exhaustion. Its pipeline includes therapies being developed for hematologic malignancies and solid tumors. Wikipedia
About Lyell Immunopharma Inc
CEO-
Employees१६१
Founded२०१८
HeadquartersSouth San Francisco, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websitelyell.com